Behavioral Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, Anxiety and Autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.

Drugs of abuse alter the way people think, feel, and behave by disrupting neurotransmission, the process of communication between brain cells. Drug dependence and addiction are features of a brain disease caused by drugs' cumulative impacts on neurotransmission. However, terrifying events can cause Post-traumatic stress disorder (PTSD). Symptoms of PTSD may include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event.

  • Anxiety and Autism
  • Measuring neural activity in drug abuse
  • Alcoholism- tolerance to and physical dependence
  • Post-traumatic stress disorder and borderline personality disorder
  • Clinical depression and enhanced treatments

Related Conference of Behavioral Neuropharmacology

July 11-13, 2016

6th Asia-Pacific Pharma Congress

Kuala Lumpur, Malaysia
July 14-15, 2016

5th Global Pharmacists Annual Meeting

Brisbane, Australia
July 14-15, 2016

International Pharmacy Conference

Philadelphia, PA, USA
July 18-20, 2016

5th Annual European Pharma Congress

Berlin,Germany
August 08-10, 2016

3rd World Congress on Pharmacology

Birmingham, UK
August 11-13, 2016

International Conference on Anatomy and Physiology

Holiday Inn Birmingham City Centre, Birmingham,UK
September 28-30, 2016

6th Pharmacovigilance Congress

Toronto, Ontario, Canada
August 22-24, 2016

2nd International Conference on Clinical Trials

Philadelphia, Pennsylvania, USA
August 22-24, 2016

7th Annual Global Pharma Summit

New Orleans, Louisiana, USA
September 05-07, 2016

Drug Formulation & Bioavailability Congress

Beijing, China
September 14-16, 2016

4th Global Experts Meeting on Neuropharmacology

San Antonio, Texas, USA
October 03-04, 2016

International Conference on Pain Research & Management

Vancouver, Canada
October 10-12, 2016

8th Annual Pharma Middle East Congress

Dubai, UAE
Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Conference on Clinical Pharmacy

Las Vegas, Nevada, USA
Nov 07-09, 2016

World Pharma Congress

Las Vegas, Nevada, USA
March 6-8, 2017

8th Global Pharmacovigilance Summit

Melbourne, Australia
March 27-29, 2017

International Conference on Medical Devices

Orlando, USA
May 25-26, 2017

World Congress on Biotherapeutics

Mexico, USA
June 12-14, 2017

World Congress on Controlled/ Sustained Release Formulations

Amsterdam, Netherlands
August 14-16, 2017

8th Asian Biosimilars Congress

Japan
Sep 25-27, 2017

Annual Pharmaceutical Analysis Conference

Vienna, Austria
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France

Behavioral Neuropharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in